Cargando…
The increasing age of respiratory syncytial virus-related hospitalisation during COVID-19 pandemic in Lyon was associated with reduced hospitalisation costs
BACKGROUND: Preventive measures applied during the COVID-19 pandemic have modified the age distribution, the clinical severity and the incidence of Respiratory Syncytial Virus (RSV) hospitalisations during the 2020/21 RSV season. The aim of the present study was to estimate the impact of these aspec...
Autores principales: | Roy, Álvaro, Polazzi, Stéphanie, Ploin, Dominique, Gillet, Yves, Javouhey, Etienne, Lina, Bruno, Myard-Dury, Anne-Florence, Couray-Targe, Sandrine, Duclos, Antoine, Casalegno, Jean-Sébastien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169568/ https://www.ncbi.nlm.nih.gov/pubmed/37198017 http://dx.doi.org/10.1016/j.vaccine.2023.05.021 |
Ejemplares similares
-
Identifying the Target Population for Primary Respiratory Syncytial Virus Two-Step Prevention in Infants: Normative Outcome of Hospitalisation Assessment for Newborns (NOHAN)
por: Jourdain, Marine, et al.
Publicado: (2022) -
Application of a forecasting model to mitigate the consequences of unexpected RSV surge: Experience from the post-COVID-19 2021/22 winter season in a major metropolitan centre, Lyon, France
por: Casalegno, Jean-Sebastien, et al.
Publicado: (2023) -
Characteristics of the delayed respiratory syncytial virus epidemic, 2020/2021, Rhône Loire, France
por: Casalegno, Jean-Sebastien, et al.
Publicado: (2021) -
Risk Factors of Very Severe RSV Infections in a Multicenter Cohort of Very Preterm and Extreme Preterm Babies Receiving or Not Palivizumab
por: Mulot, Gwenaelle, et al.
Publicado: (2022) -
Low levels of respiratory syncytial virus activity in Europe during the 2020/21 season: what can we expect in the coming summer and autumn/winter?
por: van Summeren, Jojanneke, et al.
Publicado: (2021)